Timing and Causes of Readmission After Acute Heart Failure Hospitalization—Insights From the Heart Failure Network Trials

Journal of Cardiac Failure

Volumn 22, Issue 11, 2016, Pages 875-883

  Vader, Justin M ^a   LaRue, Shane J ^a   Stevens, Susanna R ^b   Mentz, Robert J ^b   DeVore, Adam D ^b   Lala, Anuradha ^c,d   Groarke, John D ^d   AbouEzzeddine, Omar F ^e   Dunlay, Shannon M ^e   Grodin, Justin L ^f   Dávila Román, Victor G ^a   de las Fuentes, Lisa ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

^d HARVARD UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ACE inhibitor; Cardiorenal; RAAS

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CREATININE; CYSTATIN C; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FUROSEMIDE; HYDRALAZINE; NESIRITIDE; NITRIC ACID DERIVATIVE; POTASSIUM; SODIUM; URIC ACID; WARFARIN; DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DEATH; DEPRESSION; DIURETIC THERAPY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPONATREMIA; KIDNEY FAILURE; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POST HOC ANALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK FACTOR; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; WEIGHT CHANGE; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; FACTUAL DATABASE; HEART FAILURE; HEART STROKE VOLUME; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TIME FACTOR; UNITED STATES;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAUSE OF DEATH; DATABASES, FACTUAL; DIURETICS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 84975110838     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.04.014     Document Type: Article

References (31)

1. 1 Blecker, S., Paul, M., Taksler, G., Ogedegbe, G., Katz, S., Heart failure–associated hospitalizations in the United States. J Am Coll Cardiol 61 (2013), 1259–1267.
2. 2 Pfuntner, A., Wier, L.M., Steiner, C., Costs for hospital stays in the United States. HCUP statistical brief #146. Rockville, MD; Agency for Healthcare Research and Quality; Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb146.jsp, 2010.
3. 3 Steiner, C., Barrett, M., Weiss, A., HCUP projections: cardiovascular/ cerebrovascular conditions and procedures 2001 to 2012. HCUP project report #2012-02; Rockville, MD: Agency for Healthcare Research and Quality; Available at: https://www.hcup-us.ahrq.gov/reports/projections/2012-02.pdf, 2012.
4. 4 Elixhauser, A., Steiner, C., Readmissions to U.S. hospitals by diagnosis. HCUP statistical brief #153. Rockville, MD: Agency for Healthcare Research and Quality; Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb153.jsp, 2010.
5. 5 Hines, A., Barrett, M., Jiang, H., Steiner, C., Conditions with the largest number of adult hospital readmissions by payer. HCUP statistical brief #172. Rockville, MD: Agency for Healthcare Research and Quality; Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb172-Conditions-Readmissions-Payer.pdf, 2011.
6. 6 Chun, S., Tu, J. V, Wijeysundera, H.C., Austin, P.C., Wang, X., Levy, D., et al. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail 5 (2012), 414–421.
7. 7 Hall, M., Levant, S., DeFrances, C., Hospitalization for congestive heart failure: United States, 2000–2010. NCHS data brief, no. 108. Hyattsville, MD: National Center for Health Statistics; Available at: https://www.cdc.gov/nchs/data/databriefs/db108.pdf, 2012.
8. 8 Ayanian, J.Z., Weissman, J.S., Chasan-Taber, S., Epstein, A.M., Quality of care for two common illnesses in teaching and nonteaching hospitals. Health Aff 17 (1998), 194–205.
9. 9 McAlister, F.A., Au, A.G., Majumdar, S.R., Youngson, E., Padwal, R.S., Postdischarge outcomes in heart failure are better for teaching hospitals and weekday discharges. Circ Heart Fail 6 (2013), 922–929.
10. 10 Kociol, R.D., Peterson, E.D., Hammill, B.G., Flynn, K.E., Heidenreich, P.A., Piña, I.L., et al. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines–Heart Failure registry. Circ Heart Fail 5 (2012), 680–687.
11. 11 Felker, G.M., Connor, C.M.O., Braunwald, E., Loop diuretics in acute decompensated heart failure. Circ Heart Fail 2 (2009), 56–62.
12. 12 Felker, G., Lee, K., Bull, D., Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
13. 13 Bart, B.A., Goldsmith, S.R., Lee, K.L., Redfield, M.M., Felker, G.M., O'Connor, C.M., et al. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail 18 (2012), 176–182.
14. 14 Bart, B.A., Goldsmith, S.R., Lee, K.L., Givertz, M.M., O'Connor, C.M., Bull, D.A., et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367 (2012), 2296–2304.
15. 15 Chen, H.H., Ch, M.B.B., Ezzeddine, O.F.A., Anstrom, K.J., Givertz, M., Bart, B.A., et al. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail 6 (2014), 1–17.
16. 16 Chen, H.H., Anstrom, K.J., Givertz, M.M., Stevenson, L.W., Semigran, M.J., Goldsmith, S.R., et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310 (2013), 2533–2543.
17. 17 Bekelman, D.B., Havranek, E.P., Becker, D.M., Kutner, J.S., Peterson, P.N., Wittstein, I.S., et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail 13 (2007), 643–648.
18. 18 Lala, A., McNulty, S.E., Mentz, R.J., Dunlay, S.M., Vader, J.M., AbouEzzeddine, O.F., et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail 8 (2015), 741–748.
19. 19 Klein, L., Massie, B.M., Leimberger, J.D., O'Connor, C.M., Piña, I.L., Adams, K.F., et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 1 (2008), 25–33.
20. 20 Schrier, R.W., Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 1 (2008), 2–5.
21. 21 O'Connor, C.M., Miller, A.B., Blair, J.A., Konstam, M.A., Wedge, P., Bahit, M.C., et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) program. Am Heart J 159 (2010), 841–849 e1.
22. 22 Braunstein, J.B., Anderson, G.F., Gerstenblith, G., Weller, W., Niefeld, M., Herbert, R., et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42 (2003), 1226–1233.
23. 23 Ambrosy, A.P., Vaduganathan, M., Mentz, R.J., Greene, S.J., Subačius, H., Konstam, M.A., et al. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan (EVEREST) trial. Am Heart J 165 (2013), 216–225.
24. 24 Joynt, K., Orav, E., Jha, A., Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA 305 (2011), 675–681.
25. 25 Bueno, H., Ross, J., Wang, Y., Chen, J., Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA 303 (2010), 2141–2147.
26. 26 Eapen, Z.J., Reed, S.D., Li, Y., Kociol, R.D., Armstrong, P.W., Starling, R.C., et al. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates? Findings from ASCEND-HF. Circ Heart Fail 6 (2013), 727–732.
27. 27 Johnson, T.J., Basu, S., Pisani, B.A., Avery, E.F., Mendez, J.C., Calvin, J.E., et al. Depression predicts repeated heart failure hospitalizations. J Card Fail 18 (2012), 246–252.
28. 28 Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Califf, R.M., Krishnan, R.R., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161 (2015), 1849–1856.
29. 29 O'Connor, C.M., Jiang, W., Kuchibhatla, M., Silva, S.G., Cuffe, M.S., Callwood, D.D., et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56 (2010), 692–699.
30. 30 Lassus, J., Zannad, F., Krum, H., McMurray, J.J.V., Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency practical considerations from published data. J Am Coll Cardiol 63 (2014), 853–871.
31. 31 Kociol, R.D., Horton, J.R., Fonarow, G.C., Reyes, E.M., Shaw, L.K., O'Connor, C.M., et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail 4 (2011), 628–636.